Header Logo

Connection

HOWARD WEINER to Treatment Outcome

Back to Details
This is a "connection" page, showing publications HOWARD WEINER has written about Treatment Outcome.
HOWARD WEINER
Connection Strength
1.218
Treatment Outcome
  1. Old Lesions and New Targets: sEEG-Identified Onsets in Traditionally Inoperable Epilepsy Lesions and Associated Surgical Outcomes. Pediatr Neurosurg. 2026; 61(1):56-66.
    View in: PubMed
    Score: 0.079
  2. Seizure outcomes after resection of primary brain tumors in pediatric patients: a systematic review and meta-analysis. J Neurooncol. 2023 Sep; 164(3):525-533.
    View in: PubMed
    Score: 0.067
  3. Behavioral Improvements following Lesion Resection for Pediatric Epilepsy: Pediatric Psychosurgery? Pediatr Neurosurg. 2023; 58(2):80-88.
    View in: PubMed
    Score: 0.064
  4. Pediatric Vagus Nerve Stimulation: Case Series Outcomes and Future Directions. Neurosurgery. 2023 05 01; 92(5):1043-1051.
    View in: PubMed
    Score: 0.063
  5. Epilepsy Surgery in Young Children With Tuberous Sclerosis Complex: A Novel Hybrid Multimodal Surgical Approach. Neurosurgery. 2023 02 01; 92(2):398-406.
    View in: PubMed
    Score: 0.063
  6. Hemispherectomy Outcome Prediction Scale: Development and validation of a seizure freedom prediction tool. Epilepsia. 2021 05; 62(5):1064-1073.
    View in: PubMed
    Score: 0.056
  7. Invasive monitoring after resection of epileptogenic neocortical lesions in multistaged epilepsy surgery in children. Epilepsy Res. 2018 12; 148:48-54.
    View in: PubMed
    Score: 0.047
  8. Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sj?gren-Larsson Syndrome. J Child Neurol. 2017 01; 32(1):100-103.
    View in: PubMed
    Score: 0.041
  9. Bilateral invasive electroencephalography in patients with tuberous sclerosis complex: a path to surgery? J Neurosurg Pediatr. 2011 Apr; 7(4):421-30.
    View in: PubMed
    Score: 0.028
  10. Quality of life following epilepsy surgery for children with tuberous sclerosis complex. Epilepsy Behav. 2011 Mar; 20(3):561-5.
    View in: PubMed
    Score: 0.028
  11. Extraventricular subependymal giant cell tumor in a child with tuberous sclerosis complex. J Neurosurg Pediatr. 2009 Jul; 4(1):85-90.
    View in: PubMed
    Score: 0.025
  12. Brain-age defines a structural signature of outcomes after vagus nerve stimulation in children. Brain Stimul. 2026 Jul-Aug; 19(4):103117.
    View in: PubMed
    Score: 0.020
  13. A deep representation learning model to predict response to vagus nerve stimulation. Nat Commun. 2026 Apr 07; 17(1).
    View in: PubMed
    Score: 0.020
  14. Responsive neurostimulation in children, adolescents, and young Adults-Longitudinal effectiveness and safety. Neurotherapeutics. 2026 Mar; 23(2):e00865.
    View in: PubMed
    Score: 0.020
  15. Clinical outcomes following stereotactic MRI-guided laser ablation in children with tuberous sclerosis complex and intractable epilepsy. Epilepsia. 2026 Mar; 67(3):1169-1180.
    View in: PubMed
    Score: 0.019
  16. Do we agree on seizure reduction after vagus nerve stimulation? Interrater reliability of retrospective and prospective seizure frequency ratings from the CONNECTiVOS database. Epilepsia. 2026 Mar; 67(3):1317-1331.
    View in: PubMed
    Score: 0.019
  17. Hemispherotomy for Drug-Resistant Epilepsy in a Low-Resource Setting: Surgical Outcomes and Quality of Life in 23 Children Treated in a Hybrid Program in Panama. Pediatr Neurosurg. 2026; 61(1):86-99.
    View in: PubMed
    Score: 0.019
  18. A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta. Mult Scler. 2005 Oct; 11(5):573-82.
    View in: PubMed
    Score: 0.019
  19. What defines response to vagus nerve stimulation in children with drug-resistant epilepsy? A prospective cohort study from the CONNECTiVOS collaboration. Epilepsia. 2025 Oct; 66(10):3700-3715.
    View in: PubMed
    Score: 0.019
  20. Epilepsy surgery outcomes in children with tuberous sclerosis complex: a systematic review and meta-analysis. J Neurosurg Pediatr. 2025 Jun 01; 35(6):599-611.
    View in: PubMed
    Score: 0.019
  21. The extreme lateral transodontoid approach for large tumors in children in the ventral craniocervical junction. J Neurosurg Pediatr. 2025 Mar 01; 35(3):284-291.
    View in: PubMed
    Score: 0.018
  22. Laparotomy-assisted, two-port fetoscopic myelomeningocele repair: infant to preschool outcomes. J Neurosurg Pediatr. 2025 Jan 01; 35(1):10-21.
    View in: PubMed
    Score: 0.018
  23. Hippocampal resection during hemispherotomy: is it needed? Childs Nerv Syst. 2024 12; 40(12):4169-4177.
    View in: PubMed
    Score: 0.018
  24. The occipital interhemispheric transtentorial approach in infants and toddlers: efficacy and complications. Childs Nerv Syst. 2024 08; 40(8):2367-2372.
    View in: PubMed
    Score: 0.018
  25. Development of an online calculator for the prediction of seizure freedom following pediatric hemispherectomy using the Hemispherectomy Outcome Prediction Scale (HOPS). Epilepsia. 2024 01; 65(1):46-56.
    View in: PubMed
    Score: 0.017
  26. Added value of corpus callosotomy following vagus nerve stimulation in children with Lennox-Gastaut syndrome: A multicenter, multinational study. Epilepsia. 2023 12; 64(12):3205-3212.
    View in: PubMed
    Score: 0.017
  27. The role of surgery in recurrent ependymomas. J Neurosurg Pediatr. 2023 11 01; 32(5):584-589.
    View in: PubMed
    Score: 0.017
  28. Responsive Neurostimulation for the Treatment of Children With Drug-Resistant Epilepsy in Tuberous Sclerosis Complex. Pediatr Neurol. 2023 08; 145:97-101.
    View in: PubMed
    Score: 0.016
  29. An Initial Experience of Completion Hemispherotomy via Magnetic Resonance-Guided Laser Interstitial Therapy. Stereotact Funct Neurosurg. 2023; 101(3):179-187.
    View in: PubMed
    Score: 0.016
  30. Vagus nerve stimulator revision in pediatric epilepsy patients: a technical note and case series. Childs Nerv Syst. 2023 02; 39(2):435-441.
    View in: PubMed
    Score: 0.016
  31. Limited utility of structural MRI to identify the epileptogenic zone in young children with tuberous sclerosis. J Neuroimaging. 2022 09; 32(5):991-1000.
    View in: PubMed
    Score: 0.015
  32. Connectomic profiling and Vagus nerve stimulation Outcomes Study (CONNECTiVOS): a prospective observational protocol to identify biomarkers of seizure response in children and youth. BMJ Open. 2022 04 08; 12(4):e055886.
    View in: PubMed
    Score: 0.015
  33. Delayed surgical resection of central nervous system germ cell tumors. Neurosurgery. 2002 Apr; 50(4):727-33; discussion 733-4.
    View in: PubMed
    Score: 0.015
  34. Knowledge gaps for functional outcomes after multilobar resective and disconnective pediatric epilepsy surgery: Conference Proceedings of the Patient-Centered Stakeholder Meeting 2019. Epileptic Disord. 2022 Feb 01; 24(1):50-66.
    View in: PubMed
    Score: 0.015
  35. Comparison of the real-world effectiveness of vertical versus lateral functional hemispherotomy techniques for pediatric drug-resistant epilepsy: A post hoc analysis of the HOPS study. Epilepsia. 2021 11; 62(11):2707-2718.
    View in: PubMed
    Score: 0.014
  36. Epilepsy surgery in infants up to 3 months of age: Safety, feasibility, and outcomes: A multicenter, multinational study. Epilepsia. 2021 08; 62(8):1897-1906.
    View in: PubMed
    Score: 0.014
  37. Intrathecal baclofen in X-linked adrenoleukodystrophy. Pediatr Neurol. 2001 Feb; 24(2):156-8.
    View in: PubMed
    Score: 0.014
  38. Epilepsy surgery in tuberous sclerosis complex (TSC): emerging techniques and redefinition of treatment goals. Childs Nerv Syst. 2020 10; 36(10):2519-2525.
    View in: PubMed
    Score: 0.013
  39. Adult growing skull fracture mimicking a skull tumor. Acta Neurochir (Wien). 1999; 141(5):545-6.
    View in: PubMed
    Score: 0.012
  40. Epilepsy surgery in Panama: Establishment of a successful hybrid program as a model for small middle-income countries. Epilepsia. 2018 11; 59(11):2137-2144.
    View in: PubMed
    Score: 0.012
  41. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis. J Neurol Sci. 2017 Dec 15; 383:221-229.
    View in: PubMed
    Score: 0.011
  42. Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon ?-1a in MS. Neurology. 2016 Oct 04; 87(14):1464-1472.
    View in: PubMed
    Score: 0.010
  43. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet. 2016 Mar 12; 387(10023):1075-1084.
    View in: PubMed
    Score: 0.010
  44. Resection of Intraventricular Tumors in Children by Purely Endoscopic Means. World Neurosurg. 2016 Mar; 87:372-80.
    View in: PubMed
    Score: 0.010
  45. Current treatment of normal-pressure hydrocephalus: comparison of flow-regulated and differential-pressure shunt valves. Neurosurgery. 1995 Nov; 37(5):877-84.
    View in: PubMed
    Score: 0.010
  46. The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis. J Neuroimaging. 2016 Mar-Apr; 26(2):184-7.
    View in: PubMed
    Score: 0.010
  47. Resective Epilepsy Surgery for Tuberous Sclerosis in Children: Determining Predictors of Seizure Outcomes in a Multicenter Retrospective Cohort Study. Neurosurgery. 2015 Oct; 77(4):517-24; discussion 524.
    View in: PubMed
    Score: 0.010
  48. An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy. Mult Scler. 2014 Sep; 20(10):1381-90.
    View in: PubMed
    Score: 0.009
  49. Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE. Exp Neurol. 2014 May; 255:63-70.
    View in: PubMed
    Score: 0.009
  50. Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer. J Oncol Pharm Pract. 2014 Jun; 20(3):229-32.
    View in: PubMed
    Score: 0.008
  51. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet. 2012 Nov 24; 380(9856):1829-39.
    View in: PubMed
    Score: 0.008
  52. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet. 2012 Nov 24; 380(9856):1819-28.
    View in: PubMed
    Score: 0.008
  53. Stereotactic endoscopic resection and surgical management of a subependymal giant cell astrocytoma: case report. J Neurosurg Pediatr. 2012 Apr; 9(4):417-20.
    View in: PubMed
    Score: 0.008
  54. Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis. J Neurol Sci. 2011 Apr 15; 303(1-2):109-13.
    View in: PubMed
    Score: 0.007
  55. Intrathecal baclofen therapy: complication avoidance and management. Childs Nerv Syst. 2011 Mar; 27(3):421-7.
    View in: PubMed
    Score: 0.007
  56. Intracranial microvascular free flaps. J Reconstr Microsurg. 2009 Feb; 25(2):89-95.
    View in: PubMed
    Score: 0.006
  57. Epilepsy surgery in tuberous sclerosis complex: early predictive elements and outcome. Childs Nerv Syst. 2008 Dec; 24(12):1437-45.
    View in: PubMed
    Score: 0.006
  58. Surgical outcome in tuberous sclerosis complex: a multicenter survey. Epilepsia. 2007 Aug; 48(8):1625-8.
    View in: PubMed
    Score: 0.005
  59. Cortical abnormalities in epilepsy revealed by local EEG synchrony. Neuroimage. 2007 Mar; 35(1):140-8.
    View in: PubMed
    Score: 0.005
  60. Developmental outcome of epilepsy surgery in tuberous sclerosis complex. Epileptic Disord. 2005 Dec; 7(4):321-6.
    View in: PubMed
    Score: 0.005
  61. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol. 2004 Dec 15; 22(24):4881-7.
    View in: PubMed
    Score: 0.005
  62. Endoscopic third ventriculostomy in patients with cerebrospinal fluid infection and/or hemorrhage. J Neurosurg. 2002 Sep; 97(3):519-24.
    View in: PubMed
    Score: 0.004
  63. Epilepsy surgery in tuberous sclerosis: multistage procedures with bilateral or multilobar foci. J Child Neurol. 2002 Sep; 17(9):689-92.
    View in: PubMed
    Score: 0.004
  64. Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am J Ophthalmol. 1997 May; 123(5):583-92.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.